Home
>
National Drug Code (NDC)
>
ERYTHROMYCIN
ERYTHROMYCIN - 0179-0117-70 - (Erythromycin)
Drug Information of ERYTHROMYCIN
| Product NDC: | 0179-0117 |
| Proprietary Name: | ERYTHROMYCIN |
| Non Proprietary Name: | Erythromycin |
| Active Ingredient(s): | 250 mg/1 & nbsp; Erythromycin |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE, DELAYED RELEASE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of ERYTHROMYCIN
| Product NDC: | 0179-0117 |
| Labeler Name: | KAISER FOUNDATION HOSPITALS |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA062746 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20120426 |
Package Information of ERYTHROMYCIN
| Package NDC: | 0179-0117-70 |
| Package Description: | 30 CAPSULE, DELAYED RELEASE in 1 BOX, UNIT-DOSE (0179-0117-70) |
NDC Information of ERYTHROMYCIN
| NDC Code | 0179-0117-70 |
| Proprietary Name | ERYTHROMYCIN |
| Package Description | 30 CAPSULE, DELAYED RELEASE in 1 BOX, UNIT-DOSE (0179-0117-70) |
| Product NDC | 0179-0117 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Erythromycin |
| Dosage Form Name | CAPSULE, DELAYED RELEASE |
| Route Name | ORAL |
| Start Marketing Date | 20120426 |
| Marketing Category Name | ANDA |
| Labeler Name | KAISER FOUNDATION HOSPITALS |
| Substance Name | ERYTHROMYCIN |
| Strength Number | 250 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Decreased Sebaceous Gland Activity [PE],Macrolide [EPC],Macrolide Antimicrobial [EPC],Macrolides [Chemical/Ingredient] |
